Microglial impact on tau pathology in the context of the proinflammatory mediator Galectin-3
Neurodegenerative diseases are becoming an increasing social and economic burden worldwide. A subset of neurodegenerative diseases, called tauopathies, accumulate abnormally aggregated tau (a microtubule-binding protein) as one of their main pathological hallmarks. The role of microglia, the immune cells of the central nervous system, in tau pathology, has been increasingly discussed in the past y